industry Research

The Whole Exome Sequencing (WES) market is witnessing rapid growth as genomic technologies continue to transform healthcare, research, and drug discovery worldwide. Whole exome sequencing targets the protein-coding regions of the genome that contain the majority of disease-causing mutations, making it a cost-effective and high-impact diagnostic tool. The Whole Exome Sequencing Market Drivers behind this growth include rising genetic disease prevalence, declining sequencing costs, expanding precision medicine adoption, and increasing investments in genomics research. The whole exome sequencing market is projected to reach US$ 1,457.8 million by 2031, growing from US$ 414.5 million in 2023, at a robust CAGR of 17.02% during 2023–2031.

The growing integration of genomic data into clinical workflows and research programs is accelerating demand across hospitals, diagnostic laboratories, pharmaceutical companies, and academic institutions. As healthcare systems move toward preventive and personalized care models, WES is becoming a core technology for early diagnosis and targeted therapy development.

Download Sample…

The global Supercritical Fluid Chromatography (SFC) Market is witnessing consistent growth, driven by increasing adoption of advanced analytical techniques across pharmaceuticals, biotechnology, and chemical industries. With a clearly defined Supercritical Fluid Chromatography (SFC) Market Report Scope, the study covers key aspects such as application areas, end-user segments, regional analysis, competitive landscape, and emerging technological trends that are shaping the evolution of supercritical fluid chromatography worldwide.

According to industry estimates, the Supercritical Fluid Chromatography Market is expected to register a CAGR of 6.0% from 2025 to 2031, highlighting its expanding role in drug discovery, quality control, and complex molecular analysis.

The market is gaining strong momentum as laboratories and industries increasingly transition toward faster, more efficient, and environmentally sustainable separation technologies. Supercritical fluid chromatography offers significant advantages over traditional liquid chromatography, including higher resolution, reduced analysis time, and lower solvent consumption. These benefits are making SFC an essential tool in modern analytical workflows,…

The global immunoassays market is projected to witness strong expansion through 2034, supported by technological innovation, rising diagnostic demand, and increasing global healthcare investments. Diagnostic testing is becoming central to modern healthcare as early disease detection and personalized medicine gain importance worldwide. Immunoassays Market Opportunities emphasize the growing potential for innovation, expansion into emerging economies, and the development of next-generation immunoassay technologies that enable faster and more accurate diagnostics. Immunoassays market size is expected to reach US$ 41.16 Billion by 2034 from US$ 28.62 Billion in 2025. The market is anticipated to register a CAGR of 4.12% during the forecast period 2026–2034.

Immunoassays are widely used to detect and quantify biomarkers such as hormones, proteins, drugs, and infectious agents using antigen–antibody reactions. Their high sensitivity and versatility make them essential in clinical diagnostics, pharmaceutical research, and disease monitoring. As healthcare systems move toward preventive and precision medicine, the demand for advanced…

The Veterinary Molecular Diagnostics Market is witnessing significant expansion as veterinary healthcare systems increasingly adopt advanced molecular technologies for accurate and rapid disease detection. With rising concerns over zoonotic diseases, livestock epidemics, and companion animal health, demand for precise diagnostic tools is accelerating worldwide. The market is expected to register a CAGR of 8.2% from 2025 to 2031, reflecting strong adoption across veterinary clinics, diagnostic laboratories, and livestock management facilities. A comprehensive Veterinary Molecular Diagnostics Market Analysis and Overview indicates that technological innovation, disease surveillance needs, and growing pet healthcare expenditure are collectively shaping the market’s long-term trajectory.

Molecular diagnostic tools such as PCR, real-time PCR, sequencing, and microarray platforms are becoming standard in veterinary practice due to their high sensitivity and specificity. These technologies enable early detection of infectious pathogens, genetic disorders, and antimicrobial resistance patterns, significantly improving treatment outcomes. The integration of automated systems and portable diagnostic devices is further enhancing…